Hochster H - Search Results

1

A 71-year-old man with a hemorrhagic vesicular eruption.

Hamilton CE, King BA, Cowper SE, Hochster H, Leventhal JS. Hamilton CE, et al. Among authors: hochster h. Int J Dermatol. 2018 Feb;57(2):147-148. doi: 10.1111/ijd.13793. Epub 2017 Oct 23. Int J Dermatol. 2018. PMID: 29057466 No abstract available.

2

From the Guest Editor: Updates in Colorectal Cancer.

Hochster HS. Hochster HS. Cancer J. 2016 May-Jun;22(3):147-8. doi: 10.1097/PPO.0000000000000207. Cancer J. 2016. PMID: 27341590 No abstract available.

3

Metastatic Colorectal Cancer: Management With Trifluridine/Tipiracil .

White T, Larson H, Minnella A, Hochster HS. White T, et al. Among authors: hochster hs. Clin J Oncol Nurs. 2017 Apr 1;21(2):E30-E37. doi: 10.1188/17.CJON.E30-E37. Clin J Oncol Nurs. 2017. PMID: 28315543 Review.

4

A phase 2 study of oxaliplatin combined with continuous infusion topotecan for patients with previously treated ovarian cancer.

Stein SM, Tiersten A, Hochster HS, Blank SV, Pothuri B, Curtin J, Shapira I, Levinson B, Ivy P, Joseph B, Guddati AK, Muggia F. Stein SM, et al. Int J Gynecol Cancer. 2013 Nov;23(9):1577-82. doi: 10.1097/IGC.0b013e3182a809e0. Int J Gynecol Cancer. 2013. PMID: 24172094 Free PMC article. Clinical Trial.

5

Randomized trial of TAS-102 for refractory metastatic colorectal cancer.

Mayer RJ, Van Cutsem E, Falcone A, Yoshino T, Garcia-Carbonero R, Mizunuma N, Yamazaki K, Shimada Y, Tabernero J, Komatsu Y, Sobrero A, Boucher E, Peeters M, Tran B, Lenz HJ, Zaniboni A, Hochster H, Cleary JM, Prenen H, Benedetti F, Mizuguchi H, Makris L, Ito M, Ohtsu A; RECOURSE Study Group. Mayer RJ, et al. Among authors: hochster h. N Engl J Med. 2015 May 14;372(20):1909-19. doi: 10.1056/NEJMoa1414325. N Engl J Med. 2015. PMID: 25970050 Free article. Clinical Trial.

6

TAS-102: a novel antimetabolite for the 21st century.

Uboha N, Hochster HS. Uboha N, et al. Future Oncol. 2016 Jan;12(2):153-63. doi: 10.2217/fon.15.276. Epub 2015 Nov 30. Future Oncol. 2016. PMID: 26616466 Free PMC article. Review.

7

Single-Agent Therapies After Standard Combination Regimens.

Chokshi S, Hochster HS. Chokshi S, et al. Cancer J. 2016 May-Jun;22(3):205-10. doi: 10.1097/PPO.0000000000000198. Cancer J. 2016. PMID: 27341600 Review.

8

Chemotherapy induced neutropenia at 1-month mark is a predictor of overall survival in patients receiving TAS-102 for refractory metastatic colorectal cancer: a cohort study.

Kasi PM, Kotani D, Cecchini M, Shitara K, Ohtsu A, Ramanathan RK, Hochster HS, Grothey A, Yoshino T. Kasi PM, et al. BMC Cancer. 2016 Jul 13;16:467. doi: 10.1186/s12885-016-2491-y. BMC Cancer. 2016. PMID: 27412464 Free PMC article.

9

Safety of trifluridine/tipiracil in an open-label expanded-access program in elderly and younger patients with metastatic colorectal cancer.

Mayer RJ, Hochster HS, Cohen SJ, Winkler R, Makris L, Grothey A. Mayer RJ, et al. Cancer Chemother Pharmacol. 2018 Dec;82(6):961-969. doi: 10.1007/s00280-018-3686-5. Epub 2018 Oct 22. Cancer Chemother Pharmacol. 2018. PMID: 30350179 Clinical Trial.

10

FOLFIRINOX for locally advanced and metastatic pancreatic cancer: single institution retrospective review of efficacy and toxicity.

Gunturu KS, Yao X, Cong X, Thumar JR, Hochster HS, Stein SM, Lacy J. Gunturu KS, et al. Med Oncol. 2013 Mar;30(1):361. doi: 10.1007/s12032-012-0361-2. Epub 2012 Dec 28. Med Oncol. 2013. PMID: 23271209 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

245 results

Search Page

Filters